INTRODUCTION
============

Protein quality control in the endoplasmic reticulum (ER) is essential for eukaryotic cells to maintain their cellular homeostasis. Because the ER faces overload of the protein-folding capacity under certain circumstances, eukaryotic cells are armed with elaborated systems to sense folding stress in the ER and to up-regulate protein folding and degradation capacities in the ER. These signal transduction systems are called the unfolded protein response (UPR; [@B35]; [@B42]). On the UPR, ER stress signals are transferred to the cytosol by three parallel pathways, namely, the Ire1p pathway ([@B6]; [@B26]), the ATF6 pathway ([@B18]; [@B51]; [@B52]), and the PERK pathway ([@B16]; [@B40]).

Among the three systems, only the Ire1p pathway is conserved among eukaryotes, and has been studied extensively in the yeast *Saccharomyces cerevisiae*. The signal transducer Ire1p has a luminal domain that acts as an ER stress sensor and a cytosolic effector unit consisting of a kinase domain and an endonuclease domain ([@B6]; [@B26]; [@B7]). On overload of the folding capacity in the ER, Ire1p forms an oligomer to allow *trans*-autophosphorylation by the kinase domain. Concomitant activation of the endonuclease domain initiates unconventional cytoplasmic splicing of *HAC1* pre-mRNA, *HAC1*^u^ mRNA ([@B44]; [@B21]; [@B2]; [@B31]; [@B8]; [@B57]; [@B30]; [@B24]). *HAC1* encodes a bZIP-type transcription factor responsible for activating expression of UPR target genes ([@B7]; [@B27]; [@B47]; [@B22]). The resulting exons from *HAC1*^u^ mRNA are ligated to *HAC1*^i^ mRNA by tRNA ligase, Rlg1p/Trl1p ([@B45]). The primary role of Rlg1p is to ligate tRNA exons, which are also produced in the cytoplasm by tRNA splicing endonuclease on the mitochondria ([@B33]; [@B55]; [@B56]). To catalyze the tRNA and *HAC1* ligation, Rlg1p has three enzymatic activities: 2′-3′ cyclic phosphodiesterase, polynucleotide kinase, and adenylate synthetase/RNA ligase ([@B33]; reviewed in [@B19]). The *HAC1* splicing is finished by 2′-phosphotransferase, Tpt1p, which removes a 2′-phosphate left at the splicing junction of tRNA ([@B9]; [@B14]).

In the yeast UPR, there are other layers of regulation in Hac1p production than the cytoplasmic splicing. *HAC1*^u^ mRNA exists in cytosolic polysomes and in an unidentified ribonucleoprotein (RNP) under nonstress conditions ([@B23]; [@B36]). Although a part of *HAC1*^u^ mRNA is associated with polysomes, Hac1^u^p is apparently not translated because a region of the 5′ UTR of *HAC1*^u^ mRNA forms base pairs with the *HAC1* intron to attenuate translation of *HAC1*^u^ mRNA ([@B36]). It has been postulated that the splicing itself is sufficient to resolve base-pairing between the 5′ UTR and intron of *HAC1* to restart translation. However, the precise mechanism to release translational attenuation of *HAC1* mRNA has not been fully understood. Furthermore, the 3′ UTR of *HAC1*^u^ mRNA contains a signal to target itself to the Ire1p cluster formed upon ER stress ([@B1]). Interestingly, translational repression of *HAC1*^u^ mRNA is a prerequisite for this ER targeting. It indicates, paradoxically, that the translational repression achieved by the 5′ UTR--intron interaction is critical for activation of Hac1p production.

In contrast to the initial step of the unconventional splicing in the Ire1p pathway, the following steps in the Ire1p pathway are divergent among species. First, substrates of Ire1p homologues are different from organisms to organisms. Only some fungi have *HAC1* homologues as an Ire1p substrate, whereas metazoan Ire1p catalyzes cleavage of *XBP1* mRNA, a different transcription factor for the UPR ([@B53]; [@B4]; [@B38]). No substrate for Ire1p has been identified in plants, whereas two Ire1p homologues are present in the *Arabidopsis thaliana* genome ([@B29]). Second, the ligation and finishing steps of the unconventional splicing of *XBP1* mRNA in mammalian cells seem to be different from those in the yeast. For tRNA ligation, two alternative pathways were reported in mammalian cells ([@B12]; [@B58]). One of the pathways requires the same reaction steps as yeast tRNA ligation, whereas no apparent homologue of the entire yeast ligase has been found in mammalian genomes. Indeed, a part of this pathway is mediated by a different enzyme, hClp1p kinase ([@B49]). The yeast-type RNA ligation pathway, however, is unlikely to operate in the ligation of the *XBP1* exons, because knockout of the unique 2′-phosphotransferase gene in mice abolished the completion of the yeast-type RNA ligation but did not affect the UPR ([@B17]). Recently, a plant tRNA ligase homologous to yeast Rlg1p was identified in *A. thaliana*. Plant tRNA ligase has the same set of enzymatic activities as yeast Rlg1p and can complement a deletion mutant of yeast *RLG1* in tRNA splicing, whereas its functionality in the UPR has not been examined ([@B10]; [@B48]). Finally, in mammalian cells, the unspliced form of XBP1 mRNA, XBP1(U) mRNA, is not under translational repression. XBP1(U) protein is translated and supposed to act as a negative regulator of the spliced form of XBP1, pXBP1(S) ([@B54]). It is still obscure how and why such diversity of the later steps in the Ire1p pathway to achieve the UPR has been evolved.

To obtain more insight into the later steps of the Ire1p pathway, we analyzed the abilities of tRNA ligases from several organisms to replace functions of the yeast tRNA ligase in *HAC1* mRNA splicing in vivo. Although all the Rlg1p homologues tested could complement the growth defect of yeast *rlg1*Δ mutant under nonstress conditions, Rlg1p from *A. thaliana*, AtRlg1p, failed to function in the UPR. Surprisingly, AtRlg1p could ligate *HAC1* exons upon UPR, but the resulting intron was circularized and remained associated with *HAC1*^i^ messenger RNP (mRNP) to prevent it from translation. Thus, the splicing step and translational restart step were unlinked in the yeast strain expressing AtRlg1p, a kind of tRNA ligase mutant. Furthermore, we showed that yeast Rlg1p is preloaded onto *HAC1*^u^ mRNP under nonstress conditions and that the *HAC1* 5′ UTR contains a *cis* element(s) to regulate translation of the following open reading frame (ORF) by Rlg1p. These results collectively suggest that Rlg1p has a novel function in the yeast Ire1p pathway even after the completion of *HAC1* splicing, especially in the translational regulation of Hac1p.

MATERIALS AND METHODS
=====================

Strains and Plasmids
--------------------

Yeast genetic techniques are essentially described in [@B15], and other molecular biological techniques were in [@B39]. *S. cerevisiae* strains used in this study are summarized in Table S1. The plasmids and primers are listed in Table S2 and S3, respectively.

A DNA fragment containing the *ScRLG1* gene with the 5′ and 3′ flanking sequences was amplified by PCR and cloned into low-copy vectors pRS314 and pRS316 to yield pTYSC220 and pTYSC224, respectively. Chromosomal disruption of *ScRLG1* was performed with a diploid strain of W303 as described in [@B34] with a YIp plasmid, pTYSC295 \[*rlg1*Δ*::kanMX4*\]. TMSC03 and TMSC05 harboring *rlg1-4* \[T^180^I\] and *rlg1-100* \[H^148^Y\], respectively, at their chromosomal *RLG1* locus were constructed by the pop-in/pop-out method with W303-1A as a host after constructing these mutant *rlg1* genes on plasmids based on an integration vector pRS306. TYSC335 with *RLG1-protein A* at its *ScRLG1* locus was constructed from W303-1A by integrating a *protein A::CgHIS3* gene cassette with 60-base pair tabs homologous to 3′ regions of *ScRLG1* to allow in-frame fusion between *ScRLG1* and *protein A* ORFs. ORFs of fungal *RLG1* genes, *ScRLG1, KlRLG1*, and *SpRLG1*, were amplified with appropriate PCR primers from genomic DNAs of *S. cerevisiae* strain X2180-1A, *Kluyveromyces lactis* strain BY20597 and *Schizosaccharomyces pombe* strain 972, respectively. Resulting PCR fragments were inserted into XhoI/KpnI-digested pTYSC128, of which multicloning site was placed after the *CUP1* promoter and a triple hemagglutinin (3×HA) tag, to yield pTYSC418 with *HA-ScRLG1*, pTYSC441 with *HA-KlRLG1*, and pTYSC442 with *HA-SpRLG1. ScRLG1* was also subcloned to a BglII/SacII site of a FLAG-tag vector with a *URA3* marker, pTYSC462 to yield pTYSC463. For *SpRLG1* cloning, the original plasmid was constructed according to the *S. pombe* Gene DB (<http://www.genedb.org/genedb/pombe/>), but was found to be nonfunctional from a sequence error of the database. pTYSC442, described above, with the correct 5′-terminal region was constructed using a 5′-primer with a correct sequence (SpRLG1_5-2 in Table S3). A 3.35-kb *AtRLG1* ORF from the 74th Met codon (*AtRLG1*\[M74\]) was prepared from pIVEX WG1.4-Atlig ([@B10]) by digestion with SacII and Cfr9I, and cloned into the SacII/Cfr9I-digested pTYSC128 to obtain pAt-R1. The same fragment was also inserted into a SacII/Cfr9I site of pTYSC461, another FLAG-tag vector with a *TRP1* marker, but SacII sites of the insert and vector were blunted before ligation to allow in-frame fusion between the FLAG tag and *AtRLG1* ORF (pTYSC541). A 0.66-kb fragment containing Met^54^-Val^293^ of *AtRLG1* was amplified from pAt-R1 with a forward primer encoding the Met^54^-Lys^73^ sequence and an appropriate reverse primer and ligated with pAt-R1 digested with EagI and BstEII to yield pTYSC471 with *HA-AtRLG1*\[M54\].

For constructing m1--m4 *HAC1* mutants, KpnI-BamHI fragments (1.98 kb) containing the *HAC1* gene with no mutation, the m1 (replacing the intronic element with the 5′ UTR element), m2 (altering the intronic element complementary to the 5′ UTR element), m3 (replacing the 5′ UTR element with the intronic element), or m4 mutation (altering the 5′ UTR element complementary to the intronic element) was amplified by megaprimer PCR. These fragments were subcloned into a centromeric vector pASZ11 \[*CEN ADE2*\] to yield pTYSC445 (*HAC1*), pTYSC447 (*hac1-m1*), pTYSC446 (*hac1-m2*), pTYSC468 (*hac1-m3*), and pTYSC469 (*hac1-m4*). For constructing *hac1*Δ strains, an *hac1*Δ*::HIS3* fragment was amplified from a YIp plasmid, pTYSC421 \[*hac1*Δ*::HIS3*\], by PCR, and introduced to TYSC771 \[*rlg1*Δ/pTYSC418\] and TYSC774 \[*rlg1*Δ/pAt-R1\] to yield TYSC791 and TYSC793, respectively.

For construction of *HAC1-GFP* (green fluorescent protein) fusion reporters, a *GAL7p::GFP::SV40t* vector pTYSC475 was constructed, and its 0.29-kb BamHI-AgeI region with a GAL7 promoter was replaced with a 0.55-kb BamHI-AgeI fragment containing the *HAC1* promoter and its 5′ UTR to yield pTYSC476. Next, a 0.86-kb PCR fragment with the 3′ half of *HAC*1 (from G^1121^ to the end of the gene) was inserted into the SacII-KpnI sites of pTYSC476 to yield pTYSC508. Then, 24 base pairs of the BspEI-SacII region was removed, blunted, and self-ligated to obtain an in-frame fusion between *GFP* and *HAC1*^u^ ORFs (pTYSC544).

To obtain a template for in vitro transcription of *HAC1*^i^ mRNA, *HAC1*^i^ cDNA was produced from yeast total RNA with SuperScript III First Strand Synthesis System (Invitrogen, Carlsbad, CA) and amplified by PCR with primers, T7-HAC1_f1211 and HAC1_r1511-491. The fragment was inserted into a KpnI/BamHI site of pUC119 to yield pTYE493. Templates for *HAC1*^u^ mRNA, *HAC1*^i^ mRNA, and *HAC1* intron were amplified by PCR with T7-HAC1_f477 and HAC1_r1927-06 as primers and pTYSC445 as a template, T7-HAC1_f477 and HAC1_r1927-06 as primers and pTYE493 as a template, and T7-HAC1_f1211 and HAC1_r1511-491 as primers and pTYSC445 as a template, respectively. Then, RNAs were transcribed in vitro from the T7 promoter with a MEGAScript kit (Ambion, Austin, TX). After phenol/chloroform extraction and desalting with a spin column, amounts of RNAs were determined from A~260~.

All the PCR fragments for cloning were sequenced with BigDye Terminator ver. 1.1 and ABI Prism 3130 Genetic Analyzer (Applied BioSystems, Foster City, CA).

Northern Blotting and RT-PCR
----------------------------

Northern blotting was performed as essentially described in [@B39]. Total RNA prepared from yeast according to [@B55] was analyzed on 1.5% agarose gel with formaldehyde and transferred to Hybond N^+^ charged nylon membranes (GE Healthcare Biosciences, Piscataway, NJ) by the capillary transfer method. Antisense RNA probes of *HAC1*^u^ full length, *HAC1* intron, and *ACT1* decorated with digoxigenin were prepared by in vitro transcription from linearized pHAC1, pHAC1-int, and pACT1, respectively, with DIG Northern Starter Kit (Roche Diagnostics, Mannheim, Germany) according to manufacturer\'s instructions. After hybridization in 0.2×SSC, 1.0% SDS at 68°C and immunodecoration with ALP-labeled anti-digoxigenin IgG, signals were developed by the ECF system (GE Healthcare Biosciences) and read with STORM860 Image Analyzer (Molecular Dynamics, Sunnyvale, CA), or the signals were visualized by CDP-star (Roche Diagnostics) and read with LAS-4000mini (Fujifilm, Tokyo, Japan).

For RT-PCR, first strands of cDNA were generated by Superscript III First-Strand Synthesis System for RT-PCR (Invitrogen) with an oligo-(dT)~20~ primer and 1.0 μg of total RNA. The cDNAs of interest were amplified from reverse transcription (RT) reactions equivalent of 0.10 μg total RNA with appropriate primer sets (see Table S3) and ExTaq DNA polymerase (Takara Bio, Otsu, Japan). The predetermined optimal cycle number was used to amplify each transcript, for example, 22 cycles for *HAC1* and *SRP1*, 20 cycles for *ERO1* and 18 cycles for *ACT1*.

RNase H Cleavage Assay
----------------------

Oligonucleotide-directed RNase H cleavage was performed as described as in [@B28]. Briefly, 10 μg of total RNA prepared from the *HA-AtRLG1* cells was hybridized with 200 pmol of anti-sense probes a (HAC1_1310-291c) or b (HAC1_1360-41c) shown in [Figure 3](#F3){ref-type="fig"}C, and treated with 20 U of RNase H at 37°C for 30 min. RNAs were extracted by phenol/chloroform and ethanol-precipitated, and then separated with 7 M urea/5% polyacrylamide gel. The *HAC1* intron and its fragments were detected by Northern blotting with anti-sense probes a or b. Complete digestion of the *HAC1* intron was confirmed by the absence of the Northern signal when the same probe was used for the digestion and detection.

Polysome Analysis
-----------------

Polysome analysis was performed essentially as described in [@B20]. Briefly, cells cultured in appropriate conditions were treated with final 0.1 mg/ml cycloheximide and harvested. Pelleted cells were frozen and ground in the liquid N~2~ with a prechilled mortar and pestle. Cell powder was extracted with lysis buffer \[20 mM HEPES-KOH, pH 7.4, 2.0 mM Mg(OAc)~2~, 100 mM KOAc, 1.0 mM DTT, 1.0 mM PMSF, 1/1000 of Protease Inhibitor Cocktail (Roche Diagnostics)\] supplemented with 0.5 U/μl RNasin. After two sequential centrifugations at 9200 × *g* for 10 min at 4°C, supernatants were loaded onto a 10--50% sucrose gradient. The gradient was ultracentrifuged at 100,000 × *g* for 3 h at 4°C in a P28S swing rotor (Hitachi Koki, Tokyo, Japan), and fractions were collected from the top with Piston Gradient Fractionator (Biocomp Instruments, Fredericton, NB, Canada).

Native Immunoprecipitation
--------------------------

HA-fusion proteins and FLAG-fusion proteins were immunoprecipitated from the extracts prepared as above by incubating with anti-HA-agarose and with anti-FLAG M2-agarose (Sigma-Aldrich, St. Louis, MO), respectively, for 2 h at 4°C. After five-times wash with lysis buffer, protein-RNA complexes were eluted by boiling in 25 mM Tris-HCl, pH 7.5, 10 mM EDTA, and 1.0% SDS for 5 min or by incubating with 0.2 μg/μl FLAG peptide for 30 min at 4°C. After removing beads by centrifugation, a portion was set aside for Western blotting, and RNAs in the rest of the eluates were extracted with phenol/chloroform and recovered by ethanol precipitation. RNAs were also recovered from loaded and flow-through samples. For separation of polysomal and nonpolysomal fractions from the extract or the immunoprecipitate, a sample (300 μl) was loaded onto a 16/50, 18/50, or 20%/50% wt/vol discontinuous sucrose gradient (600 μl + 500 μl) and centrifuged at 160,000 × *g* for 1 h at 4°C with a CS100 microultra centrifuge (Hitachi Koki). A 400-μl fraction from the top and another 400-μl fraction containing the 16--20%/50% interface were recovered as nonribosomal and ribosomal fractions, respectively. These fractions were subjected to immunoprecipitation (IP) with anti-HA-agarose or protein/RNA analysis as described above.

RNA IP after Cross-Link
-----------------------

RNA IP after cross-link was performed as described in [@B13]. To cross-link between proteins and RNAs, final 1.0% formaldehyde was directly added to the appropriate cultures of yeast strains. After 30-min incubation, residual formaldehyde was quenched with final 350 mM glycine, and then cell extracts were prepared by eight 30-s bursts of glass-bead agitation at 90-s intervals on ice in FA lysis buffer (50 mM HEPES-KOH, pH 7.5, 140 mM NaCl, 1.0 mM EDTA, and 5.0 mM DTT) supplemented with a 1/1000 volume of Protease Inhibitor Cocktail and 100 U/ml RNasin. Then, final 1.0% Triton X-100 and 0.10% Na-deoxycholate were added, and DNA was digested by sonication and treatment with 500 U of RNase-free DNase I in the presence of 25 mM MgCl~2~ and 5.0 mM CaCl~2~. After adding final 30 mM EDTA, the extracts were centrifuged at 20,000 × *g* for 15 min. Resulting supernatants were subjected to IP with IgG-Sepharose in the presence of 10 U/ml RNasin. Proteins and RNAs were eluted from the IgG-Sepharose beads by heating at 65°C for 10 min in elution buffer (25 mM Tris-HCl, pH 7.5, 10 mM EDTA, 0.5% SDS) after an extensive wash with FA lysis buffer. RNA-protein adducts in the eluates were de-cross-linked by treating with proteinase K at 42°C for 1 h and further heating at 65°C for 5 h. Liberated RNAs were extracted with phenol/chloroform and recovered by ethanol precipitation. For RNase IP control, a part of the DNase I--treated samples was incubated with 20 μg/ml RNase A at 37°C for 10 min and then subjected to IP in the absence of RNasin.

Miscellaneous
-------------

Western blotting was performed with anti-ScRlg1p rabbit polyclonal antibodies (this study), anti-Hac1p affinity-purified rabbit polyclonal antibodies (gifted by Dr. K. Mori, Kyoto University), an anti-Pdi1p mouse mAb (38H8: EnCor Biotechnology, Gainesville, FL), an anti-HA mouse mAb (HA-7: Sigma-Aldrich), an anti-FLAG mouse mAb (M2: Sigma-Aldrich), and an anti-Por2p mouse mAb (16G9: Molecular Probes, Eugene, OR) as primary antibodies, and with Cy5-labeled (GE Healthcare Biosciences and Alexa488-labled (Molecular Probes) secondary antibodies. Signals were detected with STOR860 Image Analyzer (Molecular Dynamics, Sunnyvale, CA). Agarose gel images of RT-PCR analysis were captured with Gel Doc 2000 Gel Documentation System (Bio-Rad Laboratories, Hercules, CA). For quantification, RT-PCR products were analyzed with MultiNA Microchip Electrophoresis System (Shimadzu, Kyoto, Japan).

RESULTS
=======

*RLG1* Genes from Other Organisms Can Complement *rlg1*Δ in *S. cerevisiae*, But Plant Rlg1p Cannot Substitute for ScRlg1p in the UPR Function
----------------------------------------------------------------------------------------------------------------------------------------------

In the yeast *S. cerevisiae*, Rlg1p functions both in tRNA splicing essential for cell growth and in *HAC1* splicing during the UPR. The former function can be reflected in the cell growth, and the latter in sensitivity to UPR-inducing reagents, such as tunicamycin (Tm). We thus attempted to test the abilities of various Rlg1p homologues to replace these functions of the authentic yeast Rlg1p in vivo. We selected three *RLG1* homologues from *K. lactis*, *S. pombe*, and *A. thaliana* (denoted as *KlRLG1*, *SpRLG1*, and *AtRLG1*, respectively). As summarized in [Table 1](#T1){ref-type="table"}, AtRlg1p has only weak homology to ScRlg1p (7.9% amino acid identity), whereas its overall domain organization is conserved ([@B10]; [@B48]). On the other hand, only *K. lactis* has an apparent homologue of *HAC1* on its genome.

###### 

Comparison of various Rlg1p homologues

  Organism                      Identity (%)[^a^](#TF1-1){ref-type="table-fn"}   Homologues on genome   *rlg1*Δ complementation in *S. cerevisiae*         
  ----------------------------- ------------------------------------------------ ---------------------- -------------------------------------------- ----- -----
  *Saccharomyces cerevisiae*    ---                                              Yes                    Yes                                          Yes   Yes
  *Kluyveromyces lactis*        46.6                                             Yes                    Yes                                          Yes   Yes
  *Schizosaccharomyces pombe*   27.9                                             Yes                    No                                           Yes   Yes
  *Arabidopsis thaliana*        7.9                                              Yes                    No                                           Yes   No

^a^ The percentage of amino acid identity to Rlg1p of *S. cerevisiae* was determined by Clustal W.

We expressed these Rlg1p homologues N-terminally fused with a 3×HA tag from the *CUP1* promoter under uninduced conditions. These *RLG1* genes could complement growth defects of chromosomal deletion of *ScRLG1* (for clarity, we hereafter refer *RLG1* of *S. cerevisiae* as *ScRLG1*; [Figure 1](#F1){ref-type="fig"}A). In the case of SpRlg1p, one nucleotide deletion was found in the database sequence, resulting in N-terminal extension of the ORF. Only this revised *SpRLG1* ORF was functional in *S. cerevisiae* ([Figure 1](#F1){ref-type="fig"}A, bottom left). For *AtRLG1*, similar complementation test was already reported with a short form of AtRlg1p, AtRlg1p\[M74\], starting from the 3rd Met codon in the longest ORF ([@B48]). Because the N-terminal ∼50 residues encoded by the longest *AtRLG1* ORF turned out to be a chloroplastic targeting signal ([@B11]), we also expressed AtRlg1p from the 2nd Met (AtRlg1p\[M54\]) and found that this was also functional. All the four Rlg1 proteins from the three species were expressed as proteins with expected molecular weights (Figure S1A). They were localized in the yeast cytoplasm and excluded from the nucleus (Figure S1B). We also confirmed that both the authentic ScRlg1p and protein A--tagged ScRlg1p were mainly localized in the cytosolic dots in the wild-type yeast cells (Figure S1C). Therefore, all the Rlg1p homologues can act as an RNA ligase in the cytoplasmic splicing of pre-tRNA in *S. cerevisiae*.

![RLG1 genes from various organisms complement lethality of *rlg1*Δ in *S. cerevisiae*, but only plant *RLG1* fails to complement UPR defects. (A) *RLG1* genes from *K. lactis*, *S. pombe*, and *A. thaliana* were expressed as N-terminal 3×HA fusion proteins in a *S. cerevisiae* strain TYSC474 (*rlg1*Δ/pTYSC224 \[*URA3 ScRLG1*\]), and whether these genes complement *rlg1*Δ was tested using 5′ fluoroorotic acid selection. W303-1A was also streaked as a wild-type control. None, vector plasmid; *HA-ScRLG1*, *RLG1* of *S. cerevisiae*; *HA-KlRLG1*, *RLG1* of *K. lactis*; *HA-SpRLG1*, *RLG1* of *S. pombe* with a corrected ORF; *HA-SpRLG1*\*, *RLG1* of *S. pombe* with an ORF predicted from the genome database; *HA-AtRLG1*\[M74\], *RLG1* of *A. thaliana* from the 3rd Met (\[M74\]); *HA-AtRLG1*\[M54\], that from the 2nd Met (\[M54\]). (B) The yeast cells expressing heterologous *RLG1* genes were tested for ability of the UPR by streaking these strains on a 0.25 μg/ml Tm plate. Strains tested are shown on the right.](zmk0211096410001){#F1}

Next, we asked whether the *RLG1* homologues can substitute for *ScRLG1* in the UPR. The yeast strains with *KlRLG1* and *SpRLG* as the sole *RLG1* gene, as well as the *ScRLG1* strain, grew in the presence of 0.25 μg/ml Tm, which caused accumulation of unfolded proteins in the ER through inhibition of N-glycosylation of newly synthesized secretory proteins ([Figure 1](#F1){ref-type="fig"}B; see also [Figure 2](#F2){ref-type="fig"}A). On the other hand, the *AtRLG1*\[M54\] and *AtRLG1*\[M74\] strains showed growth defects on the Tm plate, whereas the former grew better than the latter. Tm sensitivity of *AtRLG1*-expressing cells was quantified with the disk assay. An average diameter of the inhibition zone caused by a 6-mm filter disk absorbing 0.25 μg of Tm was 14.3 ± 0.3 mm for the wild-type yeast, 17.5 ± 0.3 mm for the *HA-AtRLG1*\[M54\] strain, and 18.5 ± 0.4 mm for the *HA-AtRLG1*\[M74\] strain, which confirms the higher sensitivity of *HA-AtRLG1*\[M74\] to Tm. These results suggest that the fungal homologues but not the plant homologue of Rlg1p can replace *ScRLG1* in the UPR in vivo.

![AtRlg1 proteins can splice *HAC1* mRNA, whereas *AtRLG1* strains are defective in the UPR. (A) Lysates were prepared from cultures of indicated strains in the absence (−) or presence (+) of 2.0 μg/ml Tm and then analyzed by Western blotting with anti-Hac1p antibodies (top). Appearance of unglycosylated Pdi1p (◁, ug-Pdi1p) was monitored to confirm effects of Tm (middle), and Por2p (mitochondrial porin) was used as a loading control (bottom). In the left part, yeast strains harboring *ScRLG1* genes with no mutation (wt), *rlg1-4* mutation (defective only in tRNA ligation), or *rlg1-100* mutation (defective only in *HAC1* mRNA ligation) on their chromosome were analyzed as control. Right, lysates from *rlg1*Δ strains complemented with various *RLG1* genes were analyzed. In the bottom square, twofold more of lysates and the fivefold higher concentration of the anti-Hac1p antibodies were used to detect small amounts of Hac1p produced in the *AtRLG1*\[M74\] and *AtRLG1*\[M54\] cells. (B) Total RNAs (0.10 μg) prepared from the same set of strains in A was subjected to RT-PCR of *HAC1* with a set of primers whose target was represented in the schematic drawing (arrows). *ERO1* RT-PCR was also carried out to monitor the UPR, and *ACT1* RT-PCR was done as a loading control. The top part represents RT-PCR products from yeast cells with *ScRLG1* alleles on their chromosome. In the bottom panel, RT-PCR products from *rlg1*Δ strains complemented with various *RLG1* genes on plasmids were analyzed. RT, reverse-transcription. ▶, RT-PCR fragment derived from *HAC1*^u^ mRNA; ◁, that from *HAC1*^i^ mRNA; gray triangles, RT-PCR fragments of *ERO1* and *ACT1* mRNAs. (C) A typical electrogram of sequencing reactions of the RT-PCR fragment amplified from the *AtRLG1*\[M74\] cells treated with Tm. Corresponding sequence is shown beneath the electrogram. The exon--exon junction is indicated by a vertical arrow.](zmk0211096410002){#F2}

The *AtRLG1* Strain Can Splice *HAC1*^u^ mRNA Normally
------------------------------------------------------

The above results suggested that Rlg1p from *A. thaliana* is defective in *HAC1*^u^ mRNA splicing in *S. cerevisiae*. Inability to activate the UPR though the Ire1p-Hac1p system was further tested by Western blotting of Hac1p. The UPR was induced by treatment with 2.0 μg/ml Tm for 60 min, and the effects of Tm was confirmed by appearance of the unglycosylated form of Pdi1p in Western blotting ([Figure 2](#F2){ref-type="fig"}A, middle, ug-Pdi1p). Yeast strains with the authentic *ScRLG1* ([Figure 2](#F2){ref-type="fig"}A, lanes marked with wt) and fungal *HA-RLG1* genes on plasmids ([Figure 2](#F2){ref-type="fig"}A, right gel set, lanes marked with *Sc*, *Kl*, and *Sp*) and the *rlg1-4* mutant only defective in tRNA splicing (lanes *rlg1-4*) expressed Hac1^i^p when exposed to 2.0 μg/ml Tm. A particular *rlg1* mutant sensitive to Tm, *rlg1-100* ([@B45]), could not produce Hac1^i^p (lanes *rlg1-100*). As expected, *AtRLG1* strains produced only small amounts of Hac1^i^p when exposed to Tm. The *AtRLG1*\[M54\] strain produced a larger amount of Hac1^i^p than the *AtRLG1*\[M74\] strain ([Figure 2](#F2){ref-type="fig"}A, bottom panel). These results correlate well to the sensitivity of these strains to Tm and indicate that the *AtRLG1* strains are defective in the Ire1p--Hac1p system to activate the UPR.

Then, we tested whether AtRlg1p joins the *HAC1* exons to the *HAC1*^i^ mRNA in vivo by RT-PCR. In the wild-type and *ScRLG1* strains, considerable amounts of *HAC1*^i^ mRNA were detected in the presence of 2.0 μg/ml Tm, whereas only *HAC1*^u^ mRNA was detected in the absence of Tm ([Figure 2](#F2){ref-type="fig"}B). The *rlg1-100* cells lost *HAC1*^u^ mRNA but did not accumulate *HAC1*^i^ mRNA in the presence of Tm, whereas *rlg1-4* cells normally converted the *HAC1*^u^ mRNA to the *HAC1*^i^ mRNA ([Figure 2](#F2){ref-type="fig"}B, top left). Surprisingly, the *AtRLG1* strains did splice *HAC1*^u^ mRNA to *HAC1*^i^ mRNA. As shown in [Figure 2](#F2){ref-type="fig"}B, lanes with *At*\[M54\] and *At*\[M74\], *AtRLG1* cells produced *HAC1*^i^ mRNA in the presence of Tm. The splicing efficiency was also comparable to the wild-type strain, indicating that AtRlg1p is functional as *HAC1* ligase in the yeast. On the other hand, transcriptional activation of *ERO1*, one of the UPR-regulated genes ([@B47]), was not obvious in the Tm-treated *AtRLG1* strains and was correlated to their Tm sensitivity shown in [Figure 1](#F1){ref-type="fig"}B. We noticed that the *AtRLG1* strains also produced a small but detectable amount of *HAC1*^i^ mRNA even in the absence of Tm. Deficiencies in the UPR in these strains may perturb maintenance of protein folding environments in the ER even under nonstress conditions, resulting in partial activation of Ire1p in the absence of Tm.

Although AtRlg1p can join the *HAC1* exons, it might be possible that formation of the splice junction is not correct and a frame shift is introduced to disrupt synthesis of normal Hac1^i^p. In fact, production of aberrantly spliced *HAC1* mRNA was reported when *ScRLG1* deletion is complemented by a combination of genes encoding T4 RNA ligase 1 and T4 polynucleotide kinase/3′ phosphatase ([@B43]). To examine this possibility, we sequenced the RT-PCR fragment of *HAC1*^i^ mRNA amplified from the *AtRLG1*\[M74\] cells. The sequence around the splice junction of *HAC1*^i^ mRNA was the same as that from the wild-type yeast, and no minor peaks of other nucleotides were detected in the electrogram ([Figure 2](#F2){ref-type="fig"}C). Therefore, we concluded that AtRlg1p can join the *HAC1* exons correctly like the authentic ScRlg1p in vivo even though the *Arabidopsis* genome does not have an apparent homologue of *HAC1*. Furthermore, these results indicate that the posttranscriptional defect of the *AtRLG1* strains in production of Hac1^i^p does not come from the splicing but from the translation. Because the UPR defect is more prominent in the *AtRLG1*\[M74\] strain than in the *AtRLG1*\[M54\] strain, we decided to analyze the former strain further.

*HAC1* Intron Is Circularized and Remains Associated with *HAC1*^i^ mRNA in *AtRLG1* Cells
------------------------------------------------------------------------------------------

We examined RNA species accumulating in the *AtRLG1*\[M74\] cells in more detail by Northern blotting. As shown in [Figure 3](#F3){ref-type="fig"}A, *AtRLG1* cells contained both *HAC1*^u^ and *HAC1*^i^ mRNA even in the absence of ER stress, and *HAC1*^i^ mRNA increased in amount under the ER stress conditions. This is in marked contrast to *rlg1-100* cells in which *HAC1*^u^ mRNA was lost under ER stress conditions. In addition, a short RNA that was hybridized with an anti-*HAC1*^u^ probe was detected in the *AtRLG1* cells. This RNA species was absent in the wild-type and other *ScRLG1* mutant strains. Northern blotting with an intron specific probe revealed that this is the *HAC1* intron ([Figure 3](#F3){ref-type="fig"}B).

![HAC1 intron is circularized and retained in the *AtRLG1* strain. Wild-type (*RLG1*), *rlg1-4*, *rlg1-100*, *ire1*Δ, *RLG1-HA*, and *rlg1*Δ/*HA-AtRLG1*\[M74\] strains were cultured in the presence (+ lanes) or absence (− lanes) of 2.0 μg/ml Tm for 60 min. Total RNAs were prepared and electrophoresed with 1.5% agarose/2.2 M formaldehyde gel. (A) *HAC1* RNA species were detected by Northern blotting with an anti-*HAC1*^u^ probe (top). *ACT1* mRNA was also detected as a loading control (bottom). (B) The total RNAs from the *AtRLG1*\[M74\] cells were subjected to Northern blotting with an anti-*HAC1* intron probe. Signal enhancement enables to observe the minor *HAC1*^u^ mRNA in the presence of Tm. (C) Total RNAs prepared from *HA-AtRLG1* cells were hybridized with probes a or b and treated with RNase H. In the lane labeled −, no oligonucleotide was added. RNAs recovered from the digestion were analyzed on a polyacrylamide gel. The *HAC1* intron and its fragments were visualized by Northern blotting with either of the probe a (left) or b (right). Hybridization positions of these probes on putative linear or circular *HAC1* introns are schematically described in the right.](zmk0211096410003){#F3}

One possible reason to explain accumulation of the *HAC1* intron in the *HA-AtRLG1* strain is that the intron is circularized by the action of AtRlg1p and escapes from exonucleolytic degradation. Indeed, it is reported that AtRlg1p but not ScRlg1p can circularize an intron cleaved from a pre-tRNA by splicing endonuclease in vitro ([@B33]; [@B10]). To examine whether the *HAC1* intron is circularized in the *HA-AtRLG1* cells in vivo, we performed oligonucleotide-directed RNase H cleavage ([@B28]). As shown in the right panel of [Figure 3](#F3){ref-type="fig"}C, RNase H treatment of the *HAC1* intron hybridized with an antisense oligonucleotide will produce two linear fragments if the intron is linear, but only one fragment slightly shorter than the intron will be produced if the intron is circular. We hybridized a 20mer antisense probe a (corresponding to 88th-107th of the intron) or probe b (138th-157th) to total RNA prepared from the *HA-AtRLG1* cells and then treated with RNase H. When no oligonucleotide was added, we detected two *HAC1* intron-related bands: one migrated slower than a 500-nt DNA marker and the other migrated near the 250-nt marker on 7 M urea/5% polyacrylamide gel. These bands were converted to single bands appearing near the 250-nt marker when treated with either of the oligonucleotides. No smaller fragments corresponding to possible derivatives from the linear intron were detected, indicating that most, if not all, of the *HAC1* intron is circularized in the *HA-AtRLG1* strain. We still do not know why there are two forms of the circular *HAC1* intron. It might be possible that the longer form is a dimer or concatemer of the *HAC1* intron.

The existence of the stable intron in the *AtRLG1* strain suggests that base-pairing between the 5′ UTR of the *HAC1*^i^ mRNA and the cleaved intron is still maintained in this strain to attenuate Hac1p translation. To examine this possibility, we performed sucrose density gradient centrifugation to compare distribution of *HAC1* RNA species and polysomes. *HAC1*^u^ and *HAC1*^i^ mRNAs both in *ScRLG1* and *AtRLG1* extracts appeared in two peaks in the sucrose density gradient as reported ([@B36]; [@B23]): one peak sedimented near 40S and 60S ribosomal subunits, and the other cosedimented with polysomes ([Figure 4](#F4){ref-type="fig"}). More *HAC1*^i^ was associated with polysomes than *HAC1*^u^. In the *AtRLG1* extracts, some *HAC1* intron was detected in the lighter (nonpolysomal) fraction, but its significant portion was cosedimented with polysomes ([Figure 4](#F4){ref-type="fig"}, B and D). No intron was detected in the fractions of *ScRLG1* extracts ([Figure 4](#F4){ref-type="fig"}, A and C).

![HAC1 intron is associated with polysomes in the *HA-AtRLG1* strain. Distribution of *HAC1* RNA species was examined by polysome analysis. Extracts from *HA-ScRLG1* cells (A and C) and *HA-AtRLG1*\[M74\] cells (B and D) cultured in the absence (A and B, −Tm) or the presence (C and D, +Tm) of 2.0 μg/ml Tm were subjected to 10--50% sucrose density gradient ultracentrifugation. Fractions were collected from the top (left) to the bottom (right). In each set of three panels, the top, middle, and bottom panels represent A~260~ trace, *HAC1* RNAs, and *ACT1* RNA, respectively. In the top panel of A, peak assignments are shown. In the middle panel, positions of *HAC1* RNA species were indicated in the right. Amounts of *HAC1*-related RNAs in the sucrose gradient fractions of *HA-AtRLG1* extracts from control (E) or Tm-treated (F) cells were compared with standard RNAs transcribed in vitro. In the bottom panel, Northern signals of *HAC1*^u^ mRNA (□), *HCA1*^i^ mRNA (▩) and *HAC1* intron (■) were quantified and expressed in arbitrary units. L, cell extract; Std, 0.22 fmol each of *HAC1*^u^ mRNA, *HAC1*^i^ mRNA, and *HAC1* intron.](zmk0211096410004){#F4}

Next, we examined whether the *HAC1* intron on polysomes forms a one-to-one complex with the *HAC1*^i^ mRNA to secure its association with the polysomes by measuring amounts of *HAC1* RNAs in the sucrose gradient fractions. The *HAC1*^u^ and *HAC1*^i^ mRNAs without poly-(A) and the *HAC1* intron were transcribed in vitro to obtain RNA standards, and sucrose gradient fractions from *HA-AtRLG1* cell extracts were analyzed by Northern blotting with defined amounts of these standard RNAs. As shown in [Figure 4](#F4){ref-type="fig"}, E and F, molar amounts of the *HAC1*^i^ mRNA detected in the polysomal fractions were much lower than those of the *HAC1* intron when compared with a mixture of 0.22 fmol each RNA standards (lane Std). This was more prominent in the case of Tm-untreated extracts ([Figure 4](#F4){ref-type="fig"}E). These results suggest that, in the *AtRLG1* cells, some *HAC1* intron is retained on the *HAC1*^i^ mRNA even after its splicing and remains on the polysomes after completion of translation of the mRNA and that this is one of the reasons why the *AtRLG1* strain cannot produce Hac1^i^p upon ER stress. Furthermore, the existence of the *HAC1* intron in the nonribosomal fractions indicates that the free intron is a poor substrate for cytosolic RNA degradation machinery because of its circular nature.

The 5′ UTR of *HAC1* Possesses a *cis* Element to Regulate Translation of the Following ORF, and This Regulation Depends on Rlg1p
---------------------------------------------------------------------------------------------------------------------------------

To confirm that the base-paring between the 5′ UTR and intron of *HAC1* mRNA is responsible for the translational defect of *HAC1*^i^ mRNA in the *AtRLG1* strain, we constructed a series of *hac1* mutants. As summarized in [Figure 5](#F5){ref-type="fig"}A, the 5′ UTR element from −38 to −20 of *HAC1*^u^ mRNA is almost complementary to the intronic element from 764 to 782 ([@B36]). We disrupted this complementarity by replacing the intronic element with the 5′ UTR element or vice versa (m1 and m3). We also changed either of the elements to the sequence perfectly complementary to the other (m2 and m4). These mutant *hac1* genes on a centromeric plasmid were introduced to an *ScRLG1 hac1*Δ strain or an *AtRLG1 hac1*Δ strain. First, we monitored the splicing efficiency of *HAC1*^u^ mRNA by RT-PCR. *AtRLG1* cells harboring mutant *HAC1* genes with the same sequences in the 5′ UTR, and the intron could not splice *HAC1*^u^ mRNA even in the presence of Tm ([Figure 5](#F5){ref-type="fig"}B, m1 and m3; see below). On the other hand, when the complementarity was strengthened, the efficiency of *HAC1*^u^ splicing increased even in the absence of Tm ([Figure 5](#F5){ref-type="fig"}B, m2 and m4). Similar results were obtained with the *ScRLG1* strains. Then, translation of Hac1p was checked by Western blotting. The *AtRLG1* cells harboring m1 and m3 *hac1* mutants expressed Hac1^u^p from the unspliced mRNA even in the absence of ER stress. A considerable increase of Hac1^u^p in amount was observed in the m1 mutant upon ER stress ([Figure 5](#F5){ref-type="fig"}C). These results indicate that disruption of the base-paring releases translational attenuation of *HAC1* mRNA even in the *AtRLG1* strain. On the other hand, m2 and m4 mutant cells produced amounts of Hac1^i^p similar to those of the wild-type *HAC1* cells despite the fact that the mutants produced more *HAC1*^i^ mRNA in the absence of Tm. The effects of *hac1* mutations in the *ScRLG1* background were also similar to those seen in the *AtRLG1* strains, but the effect of m1 mutation is modest in the *ScRLG1* strain when compared with that in the *AtRLG1* strain. A recent report demonstrated that the splicing of *HAC1*^u^ is dependent on translational attenuation under nonstress conditions ([@B1]). Our results are consistent with this observation. The defects of *HAC1*^u^ splicing in the m1 and m3 mutants expressed in the *AtRLG1* background may be due to translation of *HAC1*^u^ mRNA in the absence of Tm. These results also support the idea that the defects of *AtRLG1* on the UPR are linked to the impaired intron release from *HAC1*^i^ mRNP. As described above, Hac1^u^p production from the m1 mutant is up-regulated by ER stress, whereas that from m3 is not. Therefore, the 5′ UTR element on *HAC1* mRNA may be an important *cis*-element that is directly recognized by the translational machinery for regulation.

![Disruption of the base-paring between the 5′ UTR and intron of *HAC1* releases translational attenuation even in the *AtRLG1* strain. (A) Schematic drawing of *hac1* mutants and comparison of the 5′ UTR (open triangles) and intronic (gray triangles) elements of the wild-type *HAC1*. (B) RT-PCR analysis of *hac1* mutant mRNAs produced in the *ScRLG1* and *AtRLG1* strains. The *ScRLG1 hac1*Δ (top) and *AtRLG1 hac1*Δ (bottom) strains with either one of the *hac1* mutants shown in A or the wild-type *HAC1* were cultured in the absence (Tm, −) or presence (Tm, +) of 2.0 μg/m Tm, and total RNA fractions prepared from these cultures were subjected to RT-PCR as in [Figure 2](#F2){ref-type="fig"}B. (C) The protein samples were prepared from the cultures in B and analyzed by Western blotting with antibodies shown in the left as in [Figure 2](#F2){ref-type="fig"}A.](zmk0211096410005){#F5}

The above results that *AtRLG1*-expressing cells accumulate the circular intron and that prolonged interaction between the *HAC1* 5′ UTR and intron causes translational attenuation in these cells may suggest that the accumulation of the intron itself fully explains the reason for repressed translation of the spliced *HAC1*^i^ mRNA. This further suggests that the *HAC1* intron may repress the translation of unrelated ORFs following the *HAC1* 5′ UTR in trans. To test this hypothesis, we constructed *HAC1-GFP* fusion reporters described in [Figure 6](#F6){ref-type="fig"}A. In an HGH construct, a large part of the 1st exon of *HAC1* was replaced with a GFP ORF in frame to allow unconventional splicing upon ER stress. On the other hand, an HG construct has only the *HAC1* 5′ UTR in front of the GFP ORF. Both of them are expressed from the *HAC1* promoter. We introduced these reporter genes into *HA-ScRLG1* or *HA-AtRLG1* strains with wild-type *HAC1* or *hac1*Δ background and then analyzed how much of GFP proteins are translated. As shown in Western blotting of [Figure 6](#F6){ref-type="fig"}B, GFP production from both HGH and HG constructs was not affected by *HAC1* deletion in the *HA-AtRLG1* cells (see At/Wt lanes vs. At/Δ lanes), indicating that existence of the *HAC1* intron on ribosomes does not affect translation of the reporter genes with the 5′ UTR of *HAC1* in trans. Interestingly, we noticed that about twofold more GFP was translated from the HG construct in the *HA-ScRLG1* cells than that in the *HA-AtRLG1* cells. This is not an overall effect of the "*HA-AtRLG1* mutation," because translational efficiency of the control GG construct, which is under the control of the galactose-inducible promoter and does not contain any *HAC1* sequence, was not affected by *RLG1* genes ([Figure 6](#F6){ref-type="fig"}B, right). These results imply that a *cis* element in the *HAC1* 5′ UTR can act to repress translation of the following ORF even in the absence of the *HAC1* intron in cis. This negative regulation is compensated by ScRlg1p but not by AtRlg1p. On the basis of these observations, we conclude that yeast Rlg1p has a pivotal role in translational reactivation of *HAC1*^i^ mRNA in addition to the unconventional splicing.

![Rlg1p affects translation of *HAC1* 5′ UTR-containing mRNA not through splicing of the mRNA. (A) A schematic diagram of GFP reporter genes with or without *HAC1* 5′ UTR. Annealing sites of RT-PCR primers are shown by short arrows. The pair a (black arrows) was used to amplify a GFP portion of the reporter mRNAs, whereas the pair b (gray arrows) was used to monitor unconventional splicing of the HGH reporter. (B) *HA-ScRLG1* (Sc) or *HA-AtRLG1* (At) strains with the *HAC1* (Wt) or *hac1*Δ (Δ) background were transformed with a plasmid expressing either HG, HGH, or GG type GFP reporter gene. Total proteins and RNAs were prepared from the cells treated with (+) or without (−) Tm, and subjected to Western blotting and RT-PCR, respectively, to detect the gene products shown in the left. Open arrowhead, GFP-Hac1^i^p; closed arrowhead, GFP. The *SRP1* gene products were monitored as loading controls. Amounts of GFPs and corresponding RT-PCR products were quantified, and their ratios are shown in the bottom with an arbitrary unit.](zmk0211096410006){#F6}

Rlg1 Proteins Interact with *HAC1*^u^ mRNA, *HAC1*^i^ mRNA, and *HAC1* Intron
-----------------------------------------------------------------------------

If Rlg1p is involved in the translational control of the *HAC1* mRNAs, Rlg1p should interact with *HAC1* RNA species, including the *HAC1*^u^ and/or *HAC1*^i^ mRNA that are not true substrates for the ligation reaction. At least in the case of tRNA ligation, Rlg1p is known to interact with pre-tRNAs in vitro even before they are cleaved by the tRNA splicing endonuclease ([@B46]). To examine interaction between Rlg1p and *HAC1* RNA species in vivo, we immunoprecipitated Rlg1 proteins through their N-terminally attached 3×HA tag under nondenaturing conditions and analyzed associated RNA species by Northern blotting. As shown in [Figure 7](#F7){ref-type="fig"}A, both the AtRlg1p and ScRlg1p fractions immunoprecipitated from Tm-treated extracts contained both the *HAC1*^u^ and *HAC1*^i^ mRNAs, indicating that both Rlg1 proteins are associated with the *HAC1*^u^ mRNA before it is cleaved by Ire1p. In the same fraction, we also detected the *HAC1* intron in the case of AtRlg1p immunoprecipitate. All the *HAC1* RNA species were recovered when 10 mM EDTA was added to the extracts to disrupt polysomes, suggesting that interactions between Rlg1 proteins and the *HAC1* RNAs is not mediated by active translation. Because the *HAC1* intron can form base-pairing with the 5′ UTR of the *HAC1* mRNAs, the *HAC1* intron may be coprecipitated with AtRlg1p through an indirect interaction via *HAC1* mRNAs. To test this possibility, we fractionated the *AtRLG1* extracts into polysomal and nonpolysomal fractions using a two-step sucrose gradient and analyzed the fractions by IP. Preliminary experiments revealed that polysomes can sediment though a 16--20% sucrose layer by ultracentrifugation at 150,000 × *g*, whereas other proteins and RNAs do not go into the sucrose layer. As shown in [Figure 7](#F7){ref-type="fig"}B, a large portion of tRNAs but only minute amounts of 5S and 5.8S rRNAs were recovered in the upper fraction. rRNAs were mainly recovered in the lower fraction above the 50% sucrose cushion (lanes R). When AtRlg1p was immunoprecipitated from the upper and lower fractions of the 16/50% sucrose density gradient, the intron was recovered in immunoprecipitates both from the upper (nonribosomal) and lower (ribosomal) fractions. IP after the sucrose gradient reproducibly enhanced recovery of *HAC1* RNP for unknown reason. These results indicate that AtRlg1p forms an RNP(s) with the *HAC1* intron irrespective of the presence of ribosome.

![Rlg1 proteins bind both *HAC1* mRNAs and intron. (A) HA-ScRlg1p and HA-AtRlg1p\[M74\] were immunoisolated in the presence (Mg^2+^) or absence (EDTA) of Mg^2+^ from Tm-treated cell extracts with anti-HA-agarose. RNAs in each fraction were subjected to Northern blotting with the anti-*HAC1*^u^ probe. T, one-tenth of total; U, one-third of unbound fraction; B, all of bound fraction. (B) *HA-AtRLG1*\[M74\] extracts were subjected to discontinuous sucrose density gradients (16/50, 18/50, or 20%/50%) to separate the nonribosomal (N) and the ribosomal (R) fraction described schematically in the upper region. Left, a urea-PAGE image of low-molecular-weight RNAs in the N, R, and T (total) fractions of sucrose density gradients. Right, the extract from Tm-treated *AtRLG1* cells was separated to nonribosomal and ribosomal fractions with the 16/50% sucrose density gradient. RNA samples from these fractions were subjected to IP with anti-HA-agarose. Coimmunoprecipitated RNAs were analyzed as in A. Recoveries of *HAC1* RNA species in the bound fractions were shown in the bottom of the Northern images.](zmk0211096410007){#F7}

Then we devised a setup to examine whether ScRlg1p binds the *HAC1* intron because the intron accumulates only in the *AtRLG1* strains. When we constructed an *rlg1*Δ strain harboring both *HA-AtRLG1*\[M74\] and *FLAG-ScRLG1* on plasmids, it showed intermediate Tm sensitivity ([Figure 8](#F8){ref-type="fig"}A). Then, we immunoprecipitated FLAG-ScRlg1p from Tm-treated cell extracts of this strain and found that *HAC1*^u^ mRNA, *HAC1*^i^ mRNA, and *HAC1* intron were coprecipitated as in the case of AtRlg1p, whereas no such RNA was detected in the immunoprecipitate from the control strain that did not express FLAG-ScRlg1p ([Figure 8](#F8){ref-type="fig"}B, top). When we analyzed protein compositions of the immunoprecipitates, only negligible amounts of HA-AtRlg1p were found in anti-FLAG immunoprecipitates and vice versa ([Figure 8](#F8){ref-type="fig"}B, bottom). These results indicate that ScRlg1p can bind the *HAC1* intron produced by splicing reaction with HA-AtRlg1p, as well.

![ScRlg1p also interacts with the *HAC1* intron spliced by AtRlg1p. (A) HA-AtRlg1\[M74\]p and FLAG-ScRlg1p were coexpressed under the *rlg1*Δ background, and their ability to compliment UPR defects was tested on a 0.25 μg/ml Tm-containing plate (right). (B) Cell extracts were prepared from the *HA-AtRLG1*\[M74\] strain (left set) and the *HA-AtRLG1*\[M74\]/*FLAG-ScRLG1* strain (right set), and tagged proteins were immunoprecipitated with immobilized antibody-resins indicated in the row IP. Top, Northern blotting with the anti-*HAC1*^u^ probe. T, 1/10 of total sample; U, 1/10 of unbound fraction; B, 3/4 of bound fraction. Bottom, protein staining of the SDS-gel analyzing the same samples.](zmk0211096410008){#F8}

Next, we asked whether the interaction between Rlg1 proteins and *HAC1* mRNAs is direct or through ribosomes. As shown above, EDTA treatment does not inhibit coimmunoprecipitation between Rlg1 proteins and *HAC1* mRNAs. However, it may be possible that Rlg1 proteins have affinity to either ribosomes or translation factors whose affinity allows Rlg1 proteins to associate with *HAC1* mRNPs existing in the absence of Mg^2+^. To test this possibility, we performed two experiments. First, immunoprecipitates of Rlg1 proteins purified in the presence of EDTA were fractionated by the two-step sucrose density gradient to see whether *HAC1* mRNA is recovered in the nonribosomal fraction. As shown in [Figure 9](#F9){ref-type="fig"}A, large parts of *HAC1*^u^ and *HAC1*^i^ mRNAs were sedimented through the 16% sucrose layer both in the Mg^2+^ and EDTA buffers. This suggests that *HAC1* mRNAs are still associated with some large structure(s) even in the presence of 10 mM EDTA, which can disassemble polysomes. Second, we examined whether association of Rlg1 proteins with polysomes depends on *HAC1* mRNAs. We prepared extracts from the *HA-AtRLG1* and *HA-ScRLG1* strains with the *HAC1* or *hac1*Δ background and applied them to polysome analysis. Rlg1 proteins were mainly found in top fractions, as expected from their primary function as tRNA ligase. On the other hand, small but detectable portions of both Rlg1 proteins were recovered in polysomal fractions ([Figure 9](#F9){ref-type="fig"}, B and D). The sedimentation patterns were not affected by deletion of the *HAC1* gene from the chromosome ([Figure 9](#F9){ref-type="fig"}, C and E). These results imply that portions of both AtRlg1p and ScRlg1p are recruited to polysomes not through the *HAC1* mRNA but through direct interaction with ribosomal proteins or translation factors. Similar results were obtained when the wild-type yeast strain expressing authentic Rlg1p was analyzed ([Figure 9](#F9){ref-type="fig"}, F and G). Indeed, similar Rlg1p distribution on the sucrose gradient was seen in *HAC1* and *hac1*Δ strains. These and other results suggest that both ScRlg1p and AtRlg1p form the *HAC1* mRNP in part through their affinity to the translational machinery.

![Rlg1 proteins interact with polysomes irrespective of existence of *HAC1* mRNAs. (A) FLAG-AtRlg1p and FLAG-ScRlg1p were immunoprecipitated with anti-FLAG M2 agarose and eluted from the resin by incubating with a 3×FLAG peptide. The eluates were loaded onto a 16/50% step sucrose density gradient as in [Figure 7](#F7){ref-type="fig"}B. (B--E) Extracts were prepared from *HA-ScRLG1 HAC1* (B), *HA-ScRLG1 hac1*Δ (C), *HA-AtRLG1*\[M74\] *HAC1* (D), and *HA-AtRLG1*\[M74\] *hac1*Δ (E) and sedimented through a 10--50% sucrose density gradient as in [Figure 4](#F4){ref-type="fig"}. The fractions were subjected to Western blotting with an anti-HA antibody. In F and G, wild-type (W303-1A) and *hac1*Δ (TMSC09) strains with the authentic *RLG1* on their chromosome were analyzed as above, and ScRlg1p in the fractions was detected with anti-Rlg1p antibodies. L, cell extract.](zmk0211096410009){#F9}

Finally, we examined whether ScRlg1p interacts with *HAC1* mRNAs under more physiological expression conditions because ScRlg1p was overproduced in the *HA-ScRLG1* strain (Figure S1). We also adopted cross-link and immunoprecipitation (CLIP) procedures where more extensive wash can be applied ([@B13]). This would help us to confirm the interaction between ScRlg1p and *HAC1* mRNA by a method different from native IP where mild conditions are required to retain protein--RNA complexes. First, we constructed a yeast strain harboring an *RLG1-protein A* fusion gene that was integrated in the chromosomal *RLG1* locus under the control of its own promoter. Then, we treated the yeast cells with formaldehyde, prepared lysates by glass-bead lysis, and performed IP with IgG-Sepharose. RNAs recovered in the immunoprecipitates were detected by RT-PCR. Under nonstress conditions, a PCR fragment corresponding to *HAC1*^u^ mRNA was amplified from the immunoprecipitates of the *RLG1-protein A* strain, whereas essentially negligible amounts of the PCR fragment were detected when immunoprecipitates were prepared from wild-type or unrelated *KAP95-TAP* strains ([Figure 10](#F10){ref-type="fig"}A, −Tm panel; quantification graph). The *HAC1*^u^ fragment was not detected when extracts were pretreated with RNase A (lanes "RNase IP"). Amplification of *HAC1*^u^ mRNA was specific because more abundant *ACT1* mRNA was not amplified from the Rlg1-protein A immunoprecipitate ([Figure 10](#F10){ref-type="fig"}B). This suggests that the ScRlg1p interaction with translational machinery as seen in [Figure 9](#F9){ref-type="fig"} has some specificity to translating mRNAs. When yeast cells were treated with Tm to induce the UPR, both *HAC1*^u^ and *HAC1*^i^ mRNAs were recovered in the immunoprecipitate ([Figure 10](#F10){ref-type="fig"}A, +Tm panel). These results indicate that ScRlg1p interacts with the *HAC1* mRNAs irrespective to the action of Ire1p. The results also support the idea that ScRlg1p acts on translational control of Hac1p after splicing as a component of *HAC1* mRNP.

![Authentic ScRlg1p interacts with both *HAC1*^u^ and *HAC1*^i^ mRNAs. Logarithmically growing yeast cells with no (wt), *KAP95-TAP* (*KAP95-TAP*), or *ScRLG1-protein A* (*ScRLG1-prot. A*) gene integrated into the chromosome were treated with (+Tm) or without (−Tm) Tm for 30 min and then were analyzed by CLIP. After cross-linking with 1.0% formaldehyde for 30 min, extracts were prepared and subjected to IP with IgG-Sepharose. Immunoprecipitated *HAC1* mRNAs (A) and *ACT1* mRNA (B) were amplified by RT-PCR with primers represented as thick arrows in schematic drawings of the genes. T, total extract; FT, flow through; RNase IP, immunoprecipitate from the extract treated with RNase A; IP, immunoprecipitate. In A, recovery of *HAC1* mRNAs (*HAC1*^u^ in the absence of Tm and *HAC1*^i^ in the presence of Tm) in the immunoprecipitates was quantified by semiquantitative RT-PCR with a microchip electrophoresis system. The values were obtained from three independent IPs.](zmk0211096410010){#F10}

DISCUSSION
==========

In this study, we compared tRNA ligases originated from different phylogenetic positions on their functionality in the unfolded protein response in *S. cerevisiae*, where the unconventional cytoplasmic splicing and intramolecular base-pairing of *HAC1* mRNA regulate the UPR. First, we have demonstrated that Rlg1 proteins from various organisms have robust substrate recognition for ligation in the cytoplasmic splicing of *HAC1*^u^ mRNA. SpRlg1p and AtRlg1p do ligate *HAC1* exons despite the fact that both organisms do not possess any apparent homologue of *HAC1*. This is in a great contrast to substrate specificity of splicing endonuclease Ire1p. The *A. thaliana* genome has two Ire1p homologues, whereas heterologous expression of a yeast *HAC1* mini-gene in *A. thaliana* protoplasts failed to yield the spliced form of *HAC1* mRNA ([@B29]). Similar results were obtained in HeLa cells ([@B3]). These facts ostensibly suggest that substrate selection relies on Ire1p and that Rlg1p just joins any pairs of RNAs with a 5′-OH group and a 2′-3′ cyclic phosphodiester bond in an appropriate distance. However, our data discussed below in detail indicate that Rlg1p recognizes certain RNA structures, and the property of Rlg1p on substrate recognition seems to be conserved.

Although both plant and fungal Rlg1 proteins can ligate yeast *HAC1* exons produced by yeast Ire1p in vivo, only the fungal Rlg1 proteins can substitute for ScRlg1p in full activity of the UPR. Indeed, we found that AtRlg1p has some problem on releasing translational attenuation of the *HAC1*^i^ mRNA conferred by base-pairing between the 5′ UTR and intron of the *HAC1* mRNA and that the *HAC1* intron remains associated with the *HAC1*^i^ mRNA on polysomes. This phenotype of the *AtRLG1*-expressing cells is in great contrast to that of *rlg1-100* cells. In *rlg-100* cells, in which the UPR is also impaired, the first endonucleolytic step of the cytoplasmic splicing seems to be normal, but no *HAC1*^i^ mRNA is detected ([@B45]; see also [Figure 3](#F3){ref-type="fig"}), indicating that the mutant suffers from a *HAC1* exon-specific ligation defect. On the other hand, *AtRLG1* is a kind of "mutant *RLG1*" that can ligate the *HAC1* exons but lacks functions for translational restart of the *HAC1*^i^ mRNA. This is partly due to accumulation of the circularized *HAC1* intron. AtRlg1p has ability to circularize an intron cleaved from a pre-tRNA in vitro. Similar intramolecular ligation by tRNA ligase was reported in other organisms from archaea to mammal ([@B32]; [@B37]), and yeast Rlg1p might have evolved to fit requirement for the fungal UPR. Because well-known degradation systems for cytoplasmic mRNAs rely on cytoplasmic exosome and Xrn1p, both of which are exonucleases, the circular intron may well be a poor substrate for cytoplasmic RNA degradation systems. AtRlg1p may have high affinity to the circular *HAC1* intron, so that it remains on the polysomes even after completion of the *HAC1*^i^ translation. A similar *HAC1* intron-ScRlg1p complex was detected when AtRlg1p and ScRlg1p were coexpressed, indicating that the circular *HAC1* intron is released from AtRlg1p and reassociated with ScRlg1p, that is, the circular intron dynamically interacts with the Rlg1 proteins and the translational machinery.

Accumulation of the circular intron may not be the only reason why *AtRLG1* does not complement UPR defects upon deletion of the chromosomal *ScRLG1* gene. First, we found that the circular intron produced by AtRlg1p does not inhibit translation in trans, whereas it can dynamically interact with Rlg1 proteins and translational machinery (see below). Existence of the complex of the *HAC1* intron and AtRlg1p is not sufficient to suppress translation of mRNA with the *HAC1* 5′ UTR. Furthermore, the observation that the GFP reporter mRNA only with the *HAC1* 5′ UTR is translated less efficiently in the *AtRLG1* cells than in the *ScRLG1* cells indicates that ScRlg1p has ability to regulate translation of *HAC1* mRNA through its action on its 5′ UTR. We noticed that *HAC1* deletion in the *ScRLG1* cells leads to enhanced translation of the *HAC1* 5′ UTR-GFP reporter construct ([Figure 6](#F6){ref-type="fig"}B). It is possible that the *hac1*Δ cells suffer from some perturbation of ER homeostasis to activate other ER-stress--signaling pathway(s) independent of *HAC1* ([@B41]; [@B5]). This may indicate a possible signal flow to the 5′ UTR of *HAC1* through ScRlg1p. It has been believed that splicing is required and sufficient for release of the *HAC1* intron from the 5′ UTR of the *HAC1*^i^ mRNA to allow Hac1^i^p translation. However, comparison between ScRlg1p and AtRlg1p now enables us to dissect the splicing and translational restart steps in vivo and reveals that Rlg1p is the factor required for both of the steps.

Involvement of Rlg1p in the translational regulation of Hac1p is further strengthened by the observation that Rlg1p is associated with various *HAC1* RNA species that are not bona fide substrates of the ligation reaction and that this association is in part through interaction between Rlg1 proteins and the translational machinery. We first demonstrated interaction between *HAC1* RNAs and AtRlg1p by native IP. The specific interactions of ScRlg1p with both *HAC1*^u^ and *HAC1*^i^ mRNAs were also observed under the wild-type expression level of Rlg1p by CLIP experiments. These results indicate that 1) Rlg1p recognizes the *HAC1*^u^ mRNA before recognition by Ire1p, probably during formation of *HAC1*^u^ mRNP under nonstress conditions, and 2) Rlg1p remains associated with *HAC1*^i^ mRNA after splicing like in the case of the EJC complex in spliceosomal splicing ([@B25]). Therefore, ScRlg1p is supposed to act not only as a splicing enzyme but also as a marker of completion of splicing and as a translational regulator of the *HAC1* mRNA. An attractive model is that ScRlg1p resolves base-pairing between the 5′ UTR and intron of *HAC1* and activates its translation after the ligation upon the UPR by itself or by recruiting some RNA remodeling factor(s). AtRlg1p may lack such remodeling or recruiting activities in *S. cerevisiae* because of the phylogenetic distance between these two organisms. Alternatively, plant cells may not rely on translational regulation of a putative *HAC1* counterpart upon the UPR. Indeed, animal cells translate the unspliced *XBP1* mRNA, whose product has vital roles on the UPR ([@B54]; [@B50]). In any cases, substrate recognition of Rlg1p in the UPR is conserved among species, and the plant Ire1p pathway may diverge from that of yeast after this step.

In conclusion, we found that yeast tRNA ligase possesses an unexpected role as a translational regulator in the UPR. Still, we do not know how Rlg1p accomplishes translational restart of *HAC1* mRNA after its splicing in detail. When and how is Rlg1p loaded onto *HAC1*^u^ mRNA? What kinds of structural features of RNA substrates for this unconventional cytoplasmic splicing are recognized by various Rlg1 proteins? Are there any intrinsic signals coming in ScRlg1p to accelerate Hac1p translation and how is this related to the action of an as-yet unidentified *trans* factor that recognizes the *HAC1* 5′ UTR? Although our findings provide a clue to understand the precise mechanism of translational regulation coupled with the unconventional splicing during the UPR, at the same time, they raise these new questions for future works.
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ER

:   endoplasmic reticulum

HA

:   hemagglutinin

*HAC1*^i^

:   *HAC1* induced

*HAC1*^u^

:   *HAC1* uninduced

mRNP

:   messenger ribonucleoprotein

RNP

:   ribonucleoprotein

Tm

:   tunicamycin

UPR

:   unfolded protein response.
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